[Biological and therapeutic properties of erythropoietin].
In this review the authors present data on biological and medical properties and high therapeutic efficacy of recently produced recombinant drugs of alfa and beta erythropoietin in the treatment of erythropoietin-deficient anaemia in patients with malignancies, diabetes mellitus, and nephropathies of other genesis. The article contains materials of international congresses held in 2001 addressing the above issues besides the newest publications.